<VariationArchive VariationID="9769" VariationName="NM_021083.4(XK):c.938_951del (p.Asn313fs)" VariationType="Deletion" Accession="VCV000009769" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-17" DateCreated="2016-10-13" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24808" VariationID="9769">
      <GeneList>
        <Gene Symbol="XK" FullName="X-linked Kx blood group antigen, Kell and VPS13A binding protein" GeneID="7504" HGNC_ID="HGNC:12811" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37685791" stop="37732130" display_start="37685791" display_stop="37732130" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37545132" stop="37591382" display_start="37545132" display_stop="37591382" Strand="+" />
          </Location>
          <OMIM>314850</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_021083.4(XK):c.938_951del (p.Asn313fs)</Name>
      <CanonicalSPDI>NC_000023.11:37728062:TAATTGGTACCAGCTA:TA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37728063" stop="37728076" display_start="37728063" display_stop="37728076" variantLength="14" positionVCF="37728062" referenceAlleleVCF="ATAATTGGTACCAGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37587316" stop="37587329" display_start="37587316" display_stop="37587329" variantLength="14" positionVCF="37587315" referenceAlleleVCF="ATAATTGGTACCAGC" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>13-BP DEL</Name>
      </OtherNameList>
      <ProteinChange>N313fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.37587318_37587331del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.37587318_37587331del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.37728065_37728078del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.37728065_37728078del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007473.3" sequenceAccession="NG_007473" sequenceVersion="3" change="g.47186_47199del">
            <Expression>NG_007473.3:g.47186_47199del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021083.4" sequenceAccession="NM_021083" sequenceVersion="4" change="c.938_951del" MANESelect="true">
            <Expression>NM_021083.4:c.938_951del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066569.1" sequenceAccession="NP_066569" sequenceVersion="1" change="p.Asn313fs">
            <Expression>NP_066569.1:p.Asn313fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_812" sequenceAccession="LRG_812">
            <Expression>LRG_812:g.47186_47199del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_812t1" sequenceAccession="LRG_812t1">
            <Expression>LRG_812t1:c.938_951del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_812p1" sequenceAccession="LRG_812p1" change="p.Asn313fs">
            <Expression>LRG_812p1:p.Asn313fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="314850.0006" DB="OMIM" />
        <XRef Type="rs" ID="2146834690" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not confirm the published sequence change on a current reference sequence after review of PubMed 11761473.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021083.4(XK):c.938_951del (p.Asn313fs) AND McLeod neuroacanthocytosis syndrome" Accession="RCV000010423" Version="5">
        <ClassifiedConditionList TraitSetID="2723">
          <ClassifiedCondition DB="MedGen" ID="C0398568">McLeod neuroacanthocytosis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-13" MostRecentSubmission="2024-03-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11761473</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">13860532</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2723" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10628" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEUROACANTHOCYTOSIS, MCLEOD TYPE</ElementValue>
                <XRef Type="MIM" ID="300842" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCLEOD PHENOTYPE</ElementValue>
                <XRef Type="MIM" ID="300842" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">McLeod neuroacanthocytosis syndrome</ElementValue>
                <XRef ID="McLeod+neuroacanthocytosis+syndrome/8791" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018945" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">McLeod syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked McLeod syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MCLDS</ElementValue>
                <XRef Type="MIM" ID="300842" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">McLeod neuroacanthocytosis syndrome (designated as MLS throughout this review) is a multisystem disorder with central nervous system (CNS), neuromuscular, cardiovascular, and hematologic manifestations in males: CNS manifestations are a neurodegenerative basal ganglia disease including movement disorders, cognitive alterations, and psychiatric symptoms. Neuromuscular manifestations include a (mostly subclinical) sensorimotor axonopathy and muscle weakness or atrophy of different degrees. Cardiac manifestations include dilated cardiomyopathy, atrial fibrillation, and tachyarrhythmia. Hematologically, MLS is defined as a specific blood group phenotype (named after the first proband, Hugh McLeod) that results from absent expression of the Kx erythrocyte antigen and weakened expression of Kell blood group antigens. The hematologic manifestations are red blood cell acanthocytosis and compensated hemolysis. Alloantibodies in the Kell and Kx blood group system can cause strong reactions to transfusions of incompatible blood and severe anemia in affected male newborns of Kell-negative mothers. Females heterozygous for XK pathogenic variants have mosaicism for the Kell and Kx blood group antigens. Although they usually lack CNS and neuromuscular manifestations, some heterozygous females may develop clinical manifestations including chorea or late-onset cognitive decline.</Attribute>
                <XRef ID="NBK1354" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500117" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509072" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509486" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511451" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10731" />
                <XRef ID="10731" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301528</ID>
                <ID Source="BookShelf">NBK1354</ID>
              </Citation>
              <XRef ID="59306" DB="Orphanet" />
              <XRef ID="C0398568" DB="MedGen" />
              <XRef ID="MONDO:0018945" DB="MONDO" />
              <XRef Type="MIM" ID="300842" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30649" SubmissionDate="2016-10-10" DateLastUpdated="2024-03-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="314850.0006_MCLEOD SYNDROME" title="XK, 13-BP DEL_MCLEOD SYNDROME" />
        <ClinVarAccession Accession="SCV000030649" DateUpdated="2024-03-16" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In Hugh McLeod, the original propositus (Allen et al., 1961) for whom the 'McLeod phenotype' (MCLDS; 300842) is named, Danek et al. (2001) demonstrated a 13-bp deletion (1020-1033del) in the XK gene. The mutation resulted in a shift in reading frame, causing the translation machinery to terminate at a downstream, in-frame stop codon. The deletion was initiated in codon 313 and the stop codon was created at codon 336.</Attribute>
              <Citation>
                <ID Source="PubMed">13860532</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11761473</ID>
              </Citation>
              <XRef DB="OMIM" ID="300842" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XK" />
          </GeneList>
          <Name>XK, 13-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">13-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="314850.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MCLEOD SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30649" TraitType="Disease" MappingType="Name" MappingValue="MCLEOD SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0398568" Name="McLeod neuroacanthocytosis syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

